MD Mednax Inc
- Stocks
- Healthcare
- NYSE: MD
Price (delayed)
$21.69
Market cap
$1.86B
P/E Ratio
11.24
Dividend/share
N/A
EPS
$1.93
Enterprise value
$2.16B
Relative Growth:
Rel. Growth:
56
Relative Strength:
Rel. Strength:
90
Relative Valuation:
Rel. Valuation:
96
Relative Profitability:
Rel. Profitability:
82
Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of
Highlights
The net income has surged by 164% year-on-year and by 48% since the previous quarter
The company's EPS has surged by 163% YoY and by 47% QoQ
The revenue has decreased by 4.2% YoY
Key stats
What are the main financial stats of MD
Market
Valuations
Earnings
Shares outstanding
85.88M
Market cap
$1.86B
Enterprise value
$2.16B
Price to earnings (P/E)
11.24
Price to book (P/B)
2.12
Price to sales (P/S)
0.95
PEG
0.07
EV/EBIT
8.98
EV/EBITDA
8.2
EV/Sales
1.13
Revenue
$1.92B
Gross profit
$496.25M
Operating income
$198.08M
Net income
$162.19M
EBIT
$241.1M
EBITDA
$264.17M
Free cash flow
$273.39M
Per share
Balance sheet
Liquidity
EPS
$1.93
EPS diluted
$1.91
Free cash flow per share
$3.23
Book value per share
$10.23
Revenue per share
$22.72
TBVPS
$10.98
Total assets
$2.2B
Total liabilities
$1.31B
Debt
$642.27M
Equity
$890.67M
Working capital
$324.65M
Debt to equity
0.72
Current ratio
1.83
Quick ratio
1.77
Net debt/EBITDA
1.14
Margins
Efficiency
Dividend
EBITDA margin
13.7%
Gross margin
25.8%
Net margin
8.4%
Operating margin
10.3%
Return on assets
7.7%
Return on equity
19.8%
Return on invested capital
26.1%
Return on capital employed
13.3%
Return on sales
12.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MD stock price
How has the Mednax stock price performed over time
Intraday
1.17%
1 week
21.38%
1 month
23.94%
1 year
41.21%
YTD
65.32%
QTD
29.49%
Financial performance
How have Mednax's revenue and profit performed over time
Revenue
$1.92B
Gross profit
$496.25M
Operating income
$198.08M
Net income
$162.19M
Gross margin
25.8%
Net margin
8.4%
The operating margin has surged by 199% year-on-year and by 23% since the previous quarter
MD's operating income has surged by 195% year-on-year and by 21% since the previous quarter
The net margin has soared by 167% YoY and by 47% from the previous quarter
The net income has surged by 164% year-on-year and by 48% since the previous quarter
Price vs fundamentals
How does MD's price correlate with its fundamentals
Growth
What is Mednax's growth rate over time
Valuation
What is Mednax stock price valuation
P/E
11.24
P/B
2.12
P/S
0.95
EV/EBIT
8.98
EV/EBITDA
8.2
EV/Sales
1.13
The company's EPS has surged by 163% YoY and by 47% QoQ
The P/B is 41% above the last 4 quarters average of 1.5 and 18% above the 5-year quarterly average of 1.8
The equity is up by 22% YoY and by 7% QoQ
The stock's price to sales (P/S) is 58% more than its last 4 quarters average of 0.6 and 19% more than its 5-year quarterly average of 0.8
The revenue has decreased by 4.2% YoY
Efficiency
How efficient is Mednax business performance
The ROA has soared by 164% YoY and by 45% from the previous quarter
MD's return on equity has surged by 161% year-on-year and by 40% since the previous quarter
The ROIC is up by 41% from the previous quarter
The company's return on sales rose by 34% QoQ
Dividends
What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MD.
Financial health
How did Mednax financials performed over time
The total assets is 68% greater than the total liabilities
The quick ratio has grown by 30% year-on-year and by 2.9% since the previous quarter
The company's current ratio rose by 29% YoY
The debt is 28% less than the equity
MD's debt to equity is down by 23% year-on-year and by 8% since the previous quarter
The equity is up by 22% YoY and by 7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.